| CTRI Number |
CTRI/2025/11/096906 [Registered on: 04/11/2025] Trial Registered Prospectively |
| Last Modified On: |
31/10/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Other |
|
Public Title of Study
|
comparing effect of different anaesthesia techniques on immune response of the body. |
|
Scientific Title of Study
|
Effect Of Different Anaesthetic Techniques On Neutrophil To Lymphocyte Ratio And Systemic Immune Inflammation Index In Patients Undergoing Laparoscopic Tubal Ligation - A Randomised Prospective Observational Study. |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Bhukya Ajay |
| Designation |
Postgraduate in Anaesthesiology |
| Affiliation |
ESIC Medical College and Hospital |
| Address |
Department of Anaesthesiology, ESIC Medical College and Hospital, Sanathnagar, Hyderabad, Telangana - 500018
Hyderabad TELANGANA 500018 India |
| Phone |
9182803564 |
| Fax |
|
| Email |
bhukyaajay47723@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Pakhare Vandana |
| Designation |
Assistant professor |
| Affiliation |
ESIC Medical College and Hospital |
| Address |
Department of Anaesthesiology, ESIC Medical College and Hospital, Sanathnagar, Hyderabad, Telangana - 500018
Hyderabad TELANGANA 500018 India |
| Phone |
8143364196 |
| Fax |
|
| Email |
vandanapakhare@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Bhukya Ajay |
| Designation |
Postgraduate in Anaesthesiology |
| Affiliation |
ESIC Medical College and Hospital |
| Address |
Department of Anaesthesiology, ESIC Medical College and Hospital, Sanathnagar, Hyderabad, Telangana - 500018
Hyderabad TELANGANA 500018 India |
| Phone |
9182803564 |
| Fax |
|
| Email |
bhukyaajay47723@gmail.com |
|
|
Source of Monetary or Material Support
|
| Esic medical College and Hospital, Sanathnagar, Hyderabad |
|
|
Primary Sponsor
|
| Name |
ESIC Medical College and Hospital |
| Address |
Department of Anaesthesiology, ESIC Medical College, Sanathnagar, Hyderabad-500018 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr vandana pakhre |
Esi Hospital, Sanathnagar, Hyderabad, Telangana - 500018 |
Room no.3021, 3rd Floor OT Complex, Department of Anaesthesiology, ESIC Medical College and Hospital, Sanathnagar, Hyderabad, Telangana - 500018 Hyderabad TELANGANA |
8143364196
vandanapakhare@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Esic Medical College And Hospital & Esic Superspeciality Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Comparator Agent |
NLR ratio and SII ratio |
Neutrophil to Lymphocyte ratio and SII ratio is by neutrophil count multiplied with platelet count and divided by lymphocyte count |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
35.00 Year(s) |
| Gender |
Female |
| Details |
1) Women undergoing elective tubal ligation under general Anastasia Or spinal anaesthesia.
2) Belonging to ASA physical status 1 or 2.
3) Aged between 18-35 years. |
|
| ExclusionCriteria |
| Details |
1) Refusal to participate
2) Active infections or recent illness
3) Immunocompromised state
4) Chronic inflammatory conditions like SLE or RA 5) Morbid obesity |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To calculate the neutrophil lymphocyte ratio from blood counts on the day of surgery and compare the value with the neutrophil lymphocyte ratio obtained on post operative day 1 ie; 24 hours later. |
T1: just before surgey starts.
T2-24hrs after surgery. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To calculate the systemic immune inflammatory index from the routine blood counts on the day of surgery and to compare it with the value obtained 24 hours later. |
1st: just before surgey starts.
2nd: 24hrs after surgery. |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identiļ¬cation.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response (Others) - the identified data will be provided after receiving methodological sound proposal to emial id - vandanapakhare@gmail.com
- For how long will this data be available start date provided 01-01-2026 and end date provided 31-12-2026?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Following approval from ethical committee and written informed consent from the patients. The study subjects would be divided into two groups. Group G would receive general anaesthesia and group S would receive spinal anaesthesia. The patients would be randomly allocated to one of the two groups. All patients will be assessed preoperatively and informed both techniques of anaesthesia and their risks and benefits. The patients would be fasted according to current anaesthetic guidelines. Preoperative haemoglobin levels, total leukocyte counts, differential count, NLR and systemic immune inflammation index would be evaluated along with the other necessary routine investigations. On the day of surgery, IV access will be established and balanced salt solution will be commenced. All patients will be monitored using NIBP, SPo2 and ETCO2. Baseline hemodynamic parameters will be recorded. Patients allocated to group G would be induced with propofol 2mg/kg and muscle relaxation achieved with vecuronium 0.1mg/kg IV. Following ventilation with oxygen, air and sevoflurane for 3 minutes, the trachea would be intubated with size 7mm tracheal tube and anaesthesia would be maintained with oxygen and air mixture 1-2% sevoflurane titrated to maintained the hemodynamic parameters within 15-20% of basal readings. Additional muscle relaxation for top up would be administered using vecuronium 0.05mg/kg as needed. Following completion of surgery, patients would be extubated after antagonism of residual neuromuscular blockade using glycopyrrolate 0.01mg/kg and neostigmine 0.05 mg/kg. Patient allocated to the spinal anaesthesia group would receive 0.5% heavy bupivacaine at T10 interspace in the sitting position using a volume of 1.8 ml. ECG, NIBP and SPO2 would be monitored continuously throughout the procedure. Any decrease in blood pressure would be corrected immediately by the administration of phenylephrine 50 micrograms boluses to maintain the arterial blood pressure within 20% of a baseline values. |